Delaware and the R&D Tax Credit

State Credit Name: Credit for Research and Development Expenses

Expiration Date: Indefinite.

Who Can Apply? Corporations and flow-through entities

Credit Carry Forward: Unused R&D credits can be carried forward for 15 years. No carry back.

About the Credit: The total credit may not exceed 50% of the taxpayer’s tax due in any one taxable year. The credit is refundable.

Are you eligible?

R&D Tax Credit Eligibility AI Tool

Why choose us?

directive for LBI taxpayers

Pass an Audit?

directive for LBI taxpayers

Special Notes: Small businesses and start-ups with revenue less than $20 million are eligible for a credit equal to:

  • 20% of the excess of the taxpayer’s total Delaware QRE’s for the taxable year over the taxpayer’s Delaware base amount; or
  • 100% of Delaware’s apportioned share of the taxpayer’s federal R&D tax credit, calculated using the alternative simplified credit method.

The taxpayer may calculate the credit in one of two ways:

  • 10% of the excess of the taxpayer’s total Delaware QRE’s for the taxable year over the taxpayer’s Delaware base amount; or
  • 50% of Delaware’s appointed share of the taxpayer’s federal R&D tax credit, calculated using the alternative simplified credit method.

FAQ's

1. What is the Delaware Research and Development (R&D) Tax Credit?

The Delaware R&D tax credit is a state-level incentive that rewards businesses for increasing their research and development expenditures within Delaware. It is based on the federal R&D tax credit but provides additional benefits at the state level.

2. Who is eligible for the Delaware R&D tax credit?

Any business conducting qualified research activities in Delaware and claiming the federal R&D tax credit (IRC §41) may be eligible to apply for the Delaware R&D credit.

3. How is the Delaware R&D tax credit calculated?

The credit is calculated as a percentage of the business’s Delaware-based QREs (Qualified Research Expenses) above a base amount, mirroring the federal credit method. Delaware allows for two calculation methods: the Traditional Credit and the Alternative Simplified Credit (ASC).

4. What percentage of credit can a business receive in Delaware?

The credit is equal to:

  • 10% of the excess QREs over the base amount (Traditional method)
  • 50% of the federal Alternative Simplified Credit (ASC)

5. Is there a cap on how much R&D credit Delaware awards?

Yes. The state has an annual cap of $5 million in total credits. If total applications exceed the cap, the credits are prorated among qualifying applicants.

6. What are Qualified Research Expenses (QREs)?

QREs are wages, supplies, and contract research expenses related to research activities conducted in Delaware, as defined under IRC §41.

7. Is a business required to file a federal R&D credit to qualify for the Delaware version?

Yes. You must claim or be eligible to claim the federal R&D tax credit to qualify for the Delaware version.

8. Can the Delaware R&D tax credit be refunded or carried forward?

The credit is non-refundable, but unused amounts may be carried forward for up to 15 years.

9. What documentation is required with the application?

You must include:

  • A completed Form 2070AC
  • Your federal Form 6765 (Credit for Increasing Research Activities)
  • A breakdown of Delaware-based QREs
  • Supporting calculations and schedules

10. Where do you submit the Delaware R&D tax credit application?

Submit the completed application to the Delaware Division of Revenue by mail or through the Delaware Taxpayer Portal, if applicable.

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed’s office location at 3616 Kirkwood Hwy, Wilmington, Delaware provides R&D tax credit consulting and advisory services to Wilmington, Dover, Newark, Middletown and Smyrna.

If you have any questions or need further assistance, please call or email our local Delaware Partner on (302) 342-0410.
Feel free to book a quick teleconference with one of our Delaware R&D tax credit specialists at a time that is convenient for you. Click here for more information about R&D tax credit management and implementation.


Live Webinar: R&D Tax Credit Training for DE CPAs

Duration: 60 Minutes

Learning objectives include:

  • An overview of R&D Tax Credits
  • Identify Qualifying Research Activities
  • Define the 4-Part Test
  • How to substantiate activities through documentation
  • Identify Qualifying Research Expenses

Cost:                             FREE

CE/CPE credits:          Worth one hour

Knowledge Level:      Basic*

Field of Study:           Taxation

R&D Tax Credit Training for CPAs

directive for LBI taxpayers

Upcoming Webinar

 



Delaware R&D Tax Credit Filing Instructions

To claim the Research and Development (R&D) tax credit in Delaware, eligible taxpayers must apply to the Division of Revenue. This is done by submitting Form 2070AC, Application and Computation Schedule for Claiming Delaware Research and Development Tax Credits. This form must be filed by September 15th after the end of the taxable year in which the R&D expenses were incurred. It’s crucial to attach a copy of the federal research credit Form 6765 to this application, as Delaware’s credit calculation is often tied to the federal R&D credit. Once the credit is approved by the Delaware Division of Revenue, the amount from Form 2070AC must be transferred to the relevant line on Delaware Form 700, Delaware Income Tax Credit Schedule, and both forms should be attached to the taxpayer’s annual Delaware corporation income tax return.


R&D Tax Credit Training for DE CPAs

directive for LBI taxpayers

Upcoming Webinar

 

R&D Tax Credit Training for DE CFPs

bigstock Image of two young businessmen 521093561 300x200

Upcoming Webinar

 

R&D Tax Credit Training for DE SMBs

water flows 521093561 300x200

Upcoming Webinar

 


Delaware Patent of the Year – 2024/2025

Valcare Medical Inc. has been awarded the 2024/2025 Patent of the Year for their groundbreaking innovation in heart valve repair. Their invention, detailed in U.S. Patent No. 12115069, titled ‘Percutaneous annuloplasty system with anterior-posterior adjustment’, introduces a minimally invasive approach to treating heart valve defects.

The patented system enables heart surgeons to repair damaged mitral or tricuspid valves without the need for open-heart surgery. Utilizing a percutaneous (through the skin) method, the device delivers an annuloplasty ring via catheter, reducing patient risk and recovery time. The ring features an expandable design that adjusts the anterior-posterior diameter of the valve annulus, improving leaflet coaptation and reducing regurgitation.

What sets this technology apart is its precision. The internal anchor mechanism allows for selective deployment through windows in the ring, ensuring secure fixation to the heart tissue. This adjustability ensures optimal fit and function, addressing individual patient anatomy.

Valcare Medical’s innovation marks a significant advancement in cardiac care, offering a safer, more efficient alternative to traditional surgical methods. As the medical field moves towards less invasive solutions, this technology stands at the forefront, promising improved outcomes for patients worldwide.


Study Case

Business Scenario

ViewLine Productions (ViewLine) is an American, full-service media company specializing in film production and interactive media integration.  As part of the film and media industry, ViewLine Productions is constantly focusing on new product development to remain competitive in the field. It is regularly conducting R&D activities to come up with new technologies to produce the highest quality media products.

To keep up with client demand and the competitive nature of the industry,  ViewLine Productions began to reinvent their equipment to produce highly innovative products, special effects and alternative delivery channels.

ViewLine Productions had never claimed the R&D tax credit before, and was unaware that it was performing qualified research and development. To be eligible for the credit, ViewLine had to satisfy four main criteria, known as the 4-Part Test. After consulting a specialist, ViewLine realized it was eligible for the R&D Tax Credit.

Eligible R&D Activities

The R&D tax credit specialist helped ViewLine determine its qualifying R&D activities, many of which were part of the company’s daily operations. ViewLine’s qualified research expenses (QRE) included:

  • Development of new or improved products to meet changing consumer preferences;
  • Development of visual effects and animation;
  • Development of new media asset management systems;
  • New software technologies for computer gaming;
  • Improving web-based systems and interactive media.

ViewLine claimed the federal R&D tax credit and was granted more than $150,000 in credits. A sustainable methodology was also established to help the company identify, document and substantiate eligible R&D projects and costs on an ongoing basis.

Qualified Research Defined

Qualified research consists of research for the intent of developing new or improved business components. A business component is defined as any product, process, technique, invention, formula, or computer software that the taxpayer intends to hold for sale, lease, license, or actual use in the taxpayer’s trade or business.

The Four-Part Test

Activities that are eligible for the R&D Credit are described in the “Four-Part Test” which must be met for the activity to qualify as R&D.

  1. Permitted Purpose: The purpose of the activity or project must be to create new (or improve existing) functionality, performance, reliability, or quality of a business component.
  2. Elimination of Uncertainty: The taxpayer must intend to discover information that would eliminate uncertainty concerning the development or improvement of the business component. Uncertainty exists if the information available to the taxpayer does not establish the capability of development or improvement, method of development or improvement, or the appropriateness of the business component’s design.
  3. Process of Experimentation: The taxpayer must undergo a systematic process designed to evaluate one or more alternatives to achieve a result where the capability or the method of achieving that result, or the appropriate design of that result, is uncertain at the beginning of the taxpayer’s research activities.
  4. Technological in Nature: The process of experimentation used to discover information must fundamentally rely on principles of hard science such as physical or biological sciences, chemistry, engineering or computer science.

What records and specific documentation did ViewLine Productions keep?

Similar to any tax credit or deduction, ViewLine Productions had to save business records that outlined what it did in its R&D activities, including experimental activities and documents to prove that the work took place in a systematic manner. ViewLine Productions saved the following documentation as evidence:

  • Project records/ lab notes
  • Conceptual sketches
  • Design drawings
  • Photographs/ videos of various stages of build/ assembly/ testing
  • Prototypes
  • Testing protocols
  • Results or records of analysis from testing/ trial runs
  • Tax invoices
  • Patent number

By having these records on file, ViewLine confirmed that it was ‘compliance ready’ — meaning if it was audited by the IRS, it could present documentation that illustrated the progression of its R&D activity, therefore proving its R&D eligibility.

Click here to view the PDF version of this case study.

Costing Example

A company in Dover, Delaware with fewer than 50 employees had never before claimed the R&D Tax Credit. This project involved a multi-year study covering the tax years 2024– 2026. The Company qualified for the federal R&D Tax Credit of $271,832 and an additional $114,562 of state R&D Tax Credit in Delaware.

FEDERAL DELAWARE
Year Total QREs Credit Total QREs Credit
2026 $1.200.000,00 $127.166,00 $1.000.000,00 $52.986,00
2025 $850.000,00 $92.166,00 $700.000,00 $37.951,00
2024 $500.000,00 $52.500,00 $450.000,00 $23.625,00
Total $2.550.000,00 $271.832,00 $2.150.000,00 $114.562,00

Choose your state

find-us-map

Never miss a deadline again

directive for LBI taxpayers

Stay up to date on IRS processes

Discover R&D in your industry

Contact Us


Delaware Office 

Swanson Reed | Specialist R&D Tax Advisors

3616 Kirkwood Hwy,
Wilmington, DE 19808